DHI
40
3
PM
56
2
DVN
40
-2
ALLE
48
2
ETN
61
2
HOG
38
2
MMC
60
3
AN
52
2
HSY
50
5
GT
39
2
A
46
2
KIM
56
5
COP
44
-3
AAPL
55
2
JNJ
54
3
C
85
3
OKE
64
-3
PLD
33
3
PFE
38
2
EXR
26
2
DHI
40
3
PM
56
2
DVN
40
-2
ALLE
48
2
ETN
61
2
HOG
38
2
MMC
60
3
AN
52
2
HSY
50
5
GT
39
2
A
46
2
KIM
56
5
COP
44
-3
AAPL
55
2
JNJ
54
3
C
85
3
OKE
64
-3
PLD
33
3
PFE
38
2
EXR
26
2
Financhill
Back

Goldman Sachs Nasdaq-100 Premium Income ETF Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
63

GPIQ
Goldman Sachs Nasdaq-100 Premium Income ETF

Last Price:
$53.49
Seasonality Move:
-1.38%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Buy
63
Goldman Sachs Nasdaq-100 Premium Income ETF (GPIQ) is a Buy

Is Goldman Sachs Nasdaq-100 Premium Income ETF a Buy, Sell or Hold?

  • The current Goldman Sachs Nasdaq-100 Premium Income ETF [GPIQ] share price is $53.52. The Score for GPIQ is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GPIQ is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

GPIQ Stock Price Chart

What is Goldman Sachs Nasdaq-100 Premium Income ETF's stock price today?

  • The Goldman Sachs Nasdaq-100 Premium Income ETF share price today is $53.52
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPIQ is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

GPIQ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.07 Buy
Relative Strength Index (14 RSI): 57.2 Buy
Chaikin Money Flow: 576696 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.84 - 53.42) Buy
Bollinger Bands (100): (50.95 - 53.19) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

GPIQ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 52.64 Buy
20-day SMA: 52.94 Buy
50-day SMA: 52.83 Buy
200-day SMA: 49.43 Buy
8-day EMA: 52.91 Buy
20-day EMA: 52.82 Buy
50-day EMA: 52.61 Buy
200-day EMA: 50.57 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Goldman Sachs Nasdaq-100 Premium Income ETF Earnings Growth & GPIQ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Goldman Sachs Nasdaq-100 Premium Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):